Breaking News Headlines Today | Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

lifesciencesbc.ca image

News from lifesciencesbc.ca

Ground News rates lifesciencesbc.ca’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

lifesciencesbc.ca’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about lifesciencesbc.ca

Where is lifesciencesbc.ca located?lifesciencesbc.ca's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top lifesciencesbc.ca News

B.C. set to open Western Canada’s first new medical school in decades — REUTERS / ixx511

Education · British Columbia

B.C. set to open Western Canada’s first new medical school in decades

58% Left coverage: 12 sources

AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin

United States · United States

AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin

100% Center coverage: 8 sources

Acquisition expands AbbVie's psychiatry pipeline with the addition of a next-generation psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD).See the Story

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week

Boston, Massachusetts · Boston

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week

100% Left coverage: 1 sources

BOSTON--(BUSINESS WIRE)--Oct 17, 2025-See the Story

Breaking News Topics Related to lifesciencesbc.ca